Patents by Inventor Enguang FENG

Enguang FENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PD-L1 antagonist compound
    Patent number: 12091398
    Abstract: Provided is a compound represented by formula (I) and a pharmaceutical composition thereof, as well as a method for using a compound represented by formula (I) to prevent and/or treat immune-related disorders.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: September 17, 2024
    Assignee: ADLAI NORTYE BIOPHARMA CO., LTD.
    Inventors: Pan Li, Beidi Xu, Qiaodong Wen, Enguang Feng, Ji Wang, Yang Lu, Yu Zhou, Zhiyong Yu, Zhiying Huang
  • PD-L1 ANTAGONIST COMPOUND
    Publication number: 20220227733
    Abstract: Provided is a compound represented by formula (I) and a pharmaceutical composition thereof, as well as a method for using a compound represented by formula (I) to prevent and/or treat immune-related disorders.
    Type: Application
    Filed: February 20, 2020
    Publication date: July 21, 2022
    Applicant: ADLAI NORTYE BIOPHARMA CO., LTD.
    Inventors: Pan LI, Beidi XU, Qiaodong WEN, Enguang FENG, Ji WANG, Yang LU, Yu ZHOU, Zhiyong YU, Zhiying HUANG